TRPV1 and ischemia: We previously demonstrated that pharmacological activation of TRPV1 using CAP conferred a cardioprotective effect against ischemia/reperfusion injury [4] and that pharmacological inhibition or genetic deletion of TRPV1 enhanced ischemia/reperfusion injury [5].